Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs
Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs
Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs
Submitted by
admin
on March 22, 2011 - 11:07am
Source:
Bloomberg
News Tags:
Novartis
Gilenya
MS
multiple sclerosis
Teva Pharmaceuticals
Biogen Idec
Roche
Headline:
Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs
Do Not Allow Advertisers to Use My Personal information
